Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gram Positive Bacteria”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Not applicableStudy completedNCT01375621
What this trial is testing

Livestock Contact and MRSA in Rural Areas

Who this might be right for
Staphylococcus Aureus Infection
National Cancer Institute (NCI) 1,342
Early research (Phase 1)UnknownNCT02391077
What this trial is testing

A Trial Assessing Efficacy of Various Antimicrobial Techniques for Reducing Bacterial Load

Who this might be right for
Disease Due to Gram-positive Bacteria
Ministry of Health, Rwanda 33
Large-scale testing (Phase 3)Study completedNCT02142075
What this trial is testing

Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure

Who this might be right for
Renal FailureCritical CareGram Positive Bacteria
Poitiers University Hospital
Not applicableEnded earlyNCT04200508
What this trial is testing

Targeted Gown and Glove Intervention in Nursing Homes

Who this might be right for
Staphylococcus AureusCarbapenem Resistant Gram Negative Bacteria
University of Maryland, Baltimore 4
Post-approval studies (Phase 4)Ended earlyNCT00102947
What this trial is testing

Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections

Who this might be right for
Soft Tissue Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 72
Not applicableStudy completedNCT05605275
What this trial is testing

CRP and PCT as Predictors of Sepsis Cause

Who this might be right for
SepsisGram-Positive BacteremiaGram-negative Bacteremia
Osijek University Hospital 81
Not applicableStudy completedNCT03349268
What this trial is testing

Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection

Who this might be right for
Healthcare Associated InfectionClostridium Difficile InfectionInfection Due to Multidrug Resistant Bacteria
University of Michigan 25,732
Not applicableStudy completedNCT02538211
What this trial is testing

The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses

Who this might be right for
Rotavirus InfectionsIntestinal Bacteria Flora DisturbanceReaction - Vaccine Nos+2 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 63
Not applicableStudy completedNCT04959799
What this trial is testing

Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections (DALBADIA)

Who this might be right for
DiabetesInfection
Aziende Chimiche Riunite Angelini Francesco S.p.A 98
Not applicableStudy completedNCT03949751
What this trial is testing

Acne crème to Reduce Propionibacterium Acnes Load in Primary Shoulder Surgery

Who this might be right for
Shoulder Infections
Balgrist University Hospital 60
Early research (Phase 1)Looking for participantsNCT07790770
What this trial is testing

A Phase I Clinical Trial to Evaluate CMS-F021 Following Single and Multiple Doses in Healthy Participants

Who this might be right for
Superficial Skin and Soft Tissue Infections Caused by Gram-positive Bacteria
Dermavon Holdings Limited 72
Large-scale testing (Phase 3)Ended earlyNCT00055198
What this trial is testing

Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria

Who this might be right for
Gram-Positive Bacterial Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 75
Not applicableStudy completedNCT03250104
What this trial is testing

Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives

Who this might be right for
Clostridium Difficile InfectionVRE InfectionNosocomial Infection+1 more
University Hospital of Cologne 80,000
Not applicableWithdrawnNCT00296049
What this trial is testing

Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy

Who this might be right for
InfectionNeutropeniaUnspecified Adult Solid Tumor, Protocol Specific+1 more
Wake Forest University Health Sciences
Not applicableStudy completedNCT04298463
What this trial is testing

Retrospective Effectiveness Study of Dalbavancin and Other Standard of Care of the Same Class in Patients With ABSSSI

Who this might be right for
Acute Bacterial Skin and Skin Structure Infection
Aziende Chimiche Riunite Angelini Francesco S.p.A 184
Not applicableStudy completedNCT00167999
What this trial is testing

Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units

Who this might be right for
Gram-Positive Bacterial InfectionsEscherichia Coli InfectionsKlebsiella Infections
Wyeth is now a wholly owned subsidiary of Pfizer 200
Not applicableStudy completedNCT02838407
What this trial is testing

Identification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain.

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 197
Not applicableStudy completedNCT01861457
What this trial is testing

Reduction of Staph Aureus Carriage by Non-Antibiotic NOZIN® Nasal Sanitizer® Antiseptic

Who this might be right for
Infectious Disease
Medical University of South Carolina 39
Early research (Phase 1)Ended earlyNCT02013141
What this trial is testing

Telavancin Pediatric PK Study (Ages >12 Months to 17 Years)

Who this might be right for
Gram-Positive Bacterial Infections
Cumberland Pharmaceuticals 22
Not applicableStudy completedNCT02972281
What this trial is testing

Systematic Search for Primary Immunodeficiency in Adults With Infections

Who this might be right for
Complement DeficiencyAntibody DeficiencyChronic Sinus Infection+7 more
University Hospital, Lille 120
Next Page